Have you signed up for the Gross-to-Net Accounting Forum?

More and more, pharmaceutical manufacturers are realizing that nothing can be done in a vacuum. With something as complex and fundamental to an organization’s financial success as Gross-to-Net calculations, this need for collaboration is even more apparent. Before, commercial and government departments worked fairly independently, but those days are over.

At IIR’s Gross-to-Net Accounting Forum, we know how important it is to hear both sides of the GTN story – Commercial and Government. Our case studies will help you optimize accuracy and accountability over the entire pharmaceutical GTN process through internal government and commercial departmental collaboration. Case studies include:

● Account for the Government Pricing and Contracting Impact on GTN Calculations With Medicaid expansion continuing into 2014, the impact it has on pharmaceutical company financials is going to continue to grow. In this session, Jennifer Norton of Vertex Pharmaceuticals discusses how government pricing and calculations affect GTN and the operational changes in government pricing that arise that affect the overall calculation.

● Commercial Contracts and Gross-to-Net for Managed Care New legislation, new distribution channels and more complex contract structures continue to present operational challenges in managed care forecasting and accruals. In this session, Tara Brodo and Mila Tartakovsky of Daiichi Sankyo discuss process documentation, how to implement appropriate controls, and identifying risk and inefficiencies in the calculation process.

To find out more about the 2013 program, download the agenda.

As a reader of Healthcare Insights blog, you get a 15% discount off the standard rate when using code XP1811BLOG to register. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

We look forward to seeing you this June!

Best,
The GTN Accounting Forum Team

Visit our homepage
Follow us on Twitter: https://twitter.com/PharmaFinance
Join our Linkedin

Download IIR's Collaborative Summit for Oncology Management Podcast Featuring: Ira Klein

In this Executive Podcast, Mr. Klein shares his thoughts on the impact of healthcare reform on cancer care and the greatest changes and challenges managed care companies will see in the coming years. He'll also talk about Aetna's Compassionate Care Program and how this program is actively engaging Oncologists with patients early on. As the leader of the Oncology Solutions Team at Aetna, he'll bring his expertise to the all-new IIR Oncology Management Summit as Chairman and Keynote Panelist on the Real-World View on the Cancer Care System.

Download the Podcast!

IIR is introducing the Collaborative Summit for Oncology Management during a time when cancer care is undergoing a period of rapid transformation. As you strive to meet the emerging value mandate, this summit delivers multi-stakeholder perspectives on innovative managed care strategies to effectively manage costs while improving quality and effectiveness of cancer care. Influence the future of oncology management with these key event take-aways:

• Multi-stakeholder view of the oncology management marketplace

• Lessons learned from payment and healthcare delivery reform pilot programs

• Meet and collaborate with oncology leaders spearheading industry change

To learn more, download our brochure.

As a reader of the Oncology Management Professionals blog, you can use priority code XP1814BLOG to receive 15% off of the standard rate to register. If you have any questions or need any further information, feel free to email kdevery@iirusa.com or visit the webpage.

We look forward to seeing you in June!

Best,
Oncology Management Team

Visit the Oncology Management Webpage
Follow us on Twitter

Get In-Depth Coverage of Chargebacks and Medicaid Forecasting at the GTN Forum

With belts tightening across the board, the pharmaceutical and biotech industry is looking even more closely at what goes into Gross-to-Net calculations to ensure forecasts and liability accruals are as accurate as possible. Every penny counts these days! At the new Gross-to-Net Accounting Forum, you'll find branded and generic, large and small pharma experts openly discuss their GTN challenges, and most importantly, offer the best ways to overcome them and benchmark your results.

The comprehensive GTN Forum program will position you to minimize calculation variance impacting your bottom line by:

• Decreasing return reserves by properly forecasting for new product launches
• Minimizing risk of audits through departmental and government collaboration
• Anticipating and preparing for Managed Care rebates in 2014 and beyond

PLUS! There will be a dedicated pre-conference workshop dedicated to just Chargebacks! This relatively simple concept quickly becomes an elaborate undertaking that can greatly impact a pharmaceutical company's financial reporting and health. Understand the complexities of the chargeback/rebate process by attending the Chargebacks 101 Pre-Conference Workshop on Monday, June 17, 2013.

To find out more about the 2013 program, download the agenda.

As a reader of GTN blog, you get a 15% discount off the standard rate when using code XP1811BLOG to register. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

We look forward to seeing you this June!

Best,
The GTN Accounting Forum Team

Visit our Homepage
Follow us on Twitter

Download a New Podcast on Overcoming Companion Diagnostics Challenges

How will you overcome your greatest companion diagnostic challenges?

Speaker Dan Snyder

Get the answers in an exclusive podcast from the 2nd Annual Future of Companion Diagnostics Summit speaker and industry leader Dan Synder, President and COO, MolecularMD.

MolecularMD is proving that it is possible to devise and commercialize a functioning and useful companion diagnostic. Hear Dan Synder talk about how to make this possible and what you can do to drive your own business forward.

Download the Full Podcast.

You will hear how to:

• ● Overcome Challenges
• Learn from the greatest challenges facing the companion diagnostics field today and unconventional methods to overcome them, including the utilization of novel assay platforms
• ● Manage Stakeholder Relationships
• Hear best practices on how to break down silos between stakeholders so all parties communicate effectively and are satisfied in the development of companion diagnostics
• ● Structure Simultaneous Development
• Learn how to synchronize the simultaneous development and approval of drug and diagnostic
• ● Develop Key Partnerships
• Partnerships between pharma and diagnostics companies are essential. Gain insights on how best to share risk and reward and learn what are critical “go / no-go” project points.

Meet Dan and other industry experts in person in May at the 2nd Annual Future of Companion Diagnostics Summit to develop your companion diagnostic partnerships, propel market success and payer reimbursement. For more information on his session and the rest of the program, download the agenda.

As a reader of this blog, when you register to join us and mention code XP1813BLOG, you’ll save 15% off the standard rate. With this discount, you also receive access to the Medical Devices Pricing, Reimbursement and Market Access Forum! If you have any questions about this event taking place May 22-23, 2013 in Boston, feel free to email Jennifer Pereira.

Only 2 Weeks Left to Register — Save Your Seat Today

The DUALS Forum is just over two weeks away! Join us to hear all of the necessary strategies and tactics to increase care coordination and decrease costs.

By attending, you will:

• DEFINE opportunities, including financial incentives, created by serving dual eligibles.

• UNDERSTAND duals' needs in order to determine how you would have to extend your network and change your benefits to best address their needs.

• ALIGN programming by partnering with (or purchasing) a health plan that compliments your plan.

• LEVERAGE existing resources to reduce administrative costs.

• SUCCEED in providing quality, cost efficient care to dual eligibles.

Join the growing list of attendees already confirmed to participate in Baltimore on April 4–5:

Altegra Health | American Institutes for Research | Amerigroup | Blue Cross Blue Shield | BMC Healthnet Plan | Brockton Hospital | CareMore | CareSource | Catamaran | Commonwealth Care Alliance | Commonwealth Medicine | Fallon Total Care | Firstsource Solutions | Gateway Health Plan | Glenridge Healthcare Solutions | Gorman Health Group | Group Health Cooperative of Eau Claire | Health Management Associates | Health Partners | Health Policy Matters | HealthSpring | Homefirst Elderplan | KnowledgeBase Marketing | L.A. Care Health Plan | Marwood Group | Montefiore Medical Center/CMO | NARBHA | Optima Health Plan | Public Consulting Group | SCAN Health Plan | Seniorlink | United Healthcare | WellPoint |

There's still time to register!  As a reader of the D.U.A.L.S. blog, you get a 15% discount off the standard rate when using code XP1804LINK to register. To find out more about the 2013 program, download the brochure. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage.

We look forward to seeing you in Baltimore!

Best,
The D.U.A.L.S. Forum Team

The D.U.A.L.S. Homepage
The D.U.A.L.S. Twitter

Key Players Convene to Improve Quality and Cost of Cancer Care

IIR’s Collaborative Summit for Oncology Management brings together perspectives from a diverse range of companies — public and private payers, providers, health systems, patient groups, pharmaceutical companies, PBMs, and specialty pharmacies. Together, you will address key topics to uncover innovative managed care strategies that effectively manage your rising costs while gaining new ways to improve the quality and effectiveness of cancer care.

The in-depth speaker line-up at the Oncology Management Summit is comprised of experts, leaders, and executives including:

• Lee Newcomer, SVP, Oncology, Genetics and Women’s Health, UnitedHealthcare
• Ira Klein, Chief of Staff, Office of the Chief Medical Officer, Aetna
• Barbara Walters, MD, Executive Medical Director, Dartmouth – Hitchcock
• Ted Okon, Executive Director, Community Oncology Alliance (COA)
• Jan Berger, MD, Chief Medical Officer, Silverlink Communications
• Karen Fields, MD, Medical Director, Strategic Alliances, Moffitt Cancer Center
• Gwen Darien, Director, The Pathways Project
• Bruce J. Gould, MD, Medical Director, Northwest Georgia Oncology Centers
• Michael Kolodziej, MD, FACP, Medical Director, Oncology Strategy, Office of the Chief Medical Officer, Aetna
• Elan Rubinstein, PharmD, MPH, EB Rubinstein Associates
• William T. McGivney, PhD, Former NCCN CEO, McGivney Global Advisors
• Jack Whelan, Patient Advocate & Member, Personalized Medicine Coalition

To learn more, download our brochure.

As a reader of this blog, you can use priority code XP1814BLOG to receive 15% off of the standard rate to register. If you have any questions or need any further information, feel free to email kdevery@iirusa.com or visit the webpage.

We look forward to seeing you in June!

Best,
Oncology Management Team

Visit the Oncology Management Webpage
Follow us on Twitter: https://twitter.com/healthcarebiz